Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and complex condition that can have serious consequences. Historically, steroids and immunosuppressive treatments have been the mainstays of treatment, but more recently, targeted therapies have become available. In this video, Dr Michael Gingold provides a comparison of three expert consensus guidelines and overviews recent clinical trial outcomes.

Dr Sanjay Ramakrishnan is a respiratory physician at the Institute for Respiratory Health in Perth.

Dr Michael Gingold is a rheumatologist at Royal Hobart Hospital.

Dr Sanjay Swaminathan is an immunologist at Westmead and Blacktown Hospitals.

These videos were created independently by the limbic. All content was developed by the presenters and views are those of the presenters alone.

Thank you to AstraZeneca for providing an unrestricted educational grant that made this project possible.